DraftKings Inc. (DKNG)
NASDAQ: DKNG · Real-Time Price · USD
42.82
-0.28 (-0.65%)
Aug 13, 2025, 10:02 AM - Market open
Akoya Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2020 |
| 5,410 | 4,768 | 3,665 | 2,240 | 1,296 | 614.53 | Upgrade | |
Revenue Growth (YoY) | 25.80% | 30.07% | 63.60% | 72.87% | 110.90% | 90.02% | Upgrade |
Cost of Revenue | 3,072 | 2,951 | 2,292 | 1,484 | 794.16 | 346.59 | Upgrade |
Gross Profit | 2,337 | 1,817 | 1,373 | 756.19 | 501.86 | 267.94 | Upgrade |
Selling, General & Admin | 2,029 | 2,003 | 1,804 | 1,932 | 1,785 | 906.16 | Upgrade |
Research & Development | 427.32 | 397.11 | 355.16 | 318.25 | 253.66 | 168.63 | Upgrade |
Operating Expenses | 2,659 | 2,400 | 2,159 | 2,251 | 2,038 | 1,075 | Upgrade |
Operating Income | -322.37 | -582.61 | -786.17 | -1,494 | -1,536 | -806.85 | Upgrade |
Interest Expense | -18.37 | -2.96 | -2.68 | -2.65 | -2.11 | -1.07 | Upgrade |
Interest & Investment Income | 39.77 | 47.26 | 58.42 | 21.35 | 4.07 | - | Upgrade |
Earnings From Equity Investments | -0.8 | -0.47 | -0.72 | -2.9 | 2.72 | -0.57 | Upgrade |
Other Non Operating Income (Expenses) | -22.33 | -28.46 | -57.77 | 50.1 | 42.02 | -387.57 | Upgrade |
EBT Excluding Unusual Items | -324.09 | -567.24 | -788.91 | -1,429 | -1,490 | -1,196 | Upgrade |
Merger & Restructuring Charges | -11.09 | -26.39 | -3.06 | -17.32 | -25.32 | -36.41 | Upgrade |
Pretax Income | -310.7 | -593.63 | -791.97 | -1,446 | -1,515 | -1,232 | Upgrade |
Income Tax Expense | -6.23 | -86.34 | 10.17 | -67.87 | 8.27 | -0.62 | Upgrade |
Net Income | -304.47 | -507.29 | -802.14 | -1,378 | -1,523 | -1,232 | Upgrade |
Net Income to Common | -304.47 | -507.29 | -802.14 | -1,378 | -1,523 | -1,232 | Upgrade |
Shares Outstanding (Basic) | 491 | 482 | 463 | 437 | 402 | 306 | Upgrade |
Shares Outstanding (Diluted) | 491 | 482 | 463 | 437 | 402 | 306 | Upgrade |
Shares Change (YoY) | 4.13% | 4.18% | 5.98% | 8.45% | 31.71% | 65.54% | Upgrade |
EPS (Basic) | -0.62 | -1.05 | -1.73 | -3.16 | -3.78 | -4.03 | Upgrade |
EPS (Diluted) | -0.62 | -1.05 | -1.73 | -3.16 | -3.78 | -4.03 | Upgrade |
Free Cash Flow | 501.99 | 407.59 | -22.65 | -657.92 | -435.43 | -205.91 | Upgrade |
Free Cash Flow Per Share | 1.02 | 0.85 | -0.05 | -1.51 | -1.08 | -0.67 | Upgrade |
Gross Margin | 43.20% | 38.11% | 37.46% | 33.75% | 38.72% | 43.60% | Upgrade |
Operating Margin | -5.96% | -12.22% | -21.45% | -66.70% | -118.54% | -131.30% | Upgrade |
Profit Margin | -5.63% | -10.64% | -21.88% | -61.50% | -117.53% | -200.45% | Upgrade |
Free Cash Flow Margin | 9.28% | 8.55% | -0.62% | -29.37% | -33.60% | -33.51% | Upgrade |
EBITDA | -30.91 | -311.76 | -584.25 | -1,325 | -1,415 | -729.44 | Upgrade |
EBITDA Margin | -0.57% | -6.54% | -15.94% | -59.15% | -109.19% | -118.70% | Upgrade |
D&A For EBITDA | 291.47 | 270.85 | 201.92 | 169.25 | 121.14 | 77.41 | Upgrade |
EBIT | -322.37 | -582.61 | -786.17 | -1,494 | -1,536 | -806.85 | Upgrade |
EBIT Margin | -5.96% | -12.22% | -21.45% | -66.70% | -118.54% | -131.30% | Upgrade |
Advertising Expenses | - | 1,050 | 984.4 | 964.9 | 831.1 | 430.4 | Upgrade |
Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.